January 31, 2020 BONESUPPORT HOLDING AB signs an agreement on a working capital facility of SEK 60 million
January 30, 2020 Aprea Therapeutics Receives FDA Breakthrough Therapy Designation for APR-246 in Combination with Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) with a TP53 Mutation
January 29, 2020 Promising results from human PK study assessing novel ketorolac formulations for treatment of pain